Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer/GSK Levitra "Product And Use" TV Ad Stars Woman With A "Secret"

This article was originally published in The Pink Sheet Daily

Executive Summary

The campaign represents a departure from Levitra "reminder" ads with Chicago Bears Coach Mike Ditka. The new commercial features a woman discussing her significant other's experience with the erectile dysfunction drug.

You may also be interested in...



Levitra Market Share Hurt By Lack of Branded Ads At Launch, GSK Says

GSK and Bayer were hesitant to launch Levitra with full product ads because of risk info, but the Cialis branded campaign revealed consumers were not dissuaded by product risks, GSK says. Sampling and internet sales of counterfeits have slowed growth in the category.

Levitra Market Share Hurt By Lack of Branded Ads At Launch, GSK Says

GSK and Bayer were hesitant to launch Levitra with full product ads because of risk info, but the Cialis branded campaign revealed consumers were not dissuaded by product risks, GSK says. Sampling and internet sales of counterfeits have slowed growth in the category.

Bayer Seeking Levitra Label Without Alpha Blocker Contraindication

Second quarter sales for Levitra were lower than expected, hampered by a slow erectile dysfunction market, the company says. Bayer remains optimistic about long-term Levitra sales growth despite competition from Pfizer and Lilly.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel